
Opinion|Videos|October 16, 2024
Access Challenges: Bridging Insurance Gaps for MDD Innovations
Carmen Kosicek, MSN, PMHNP-BC shares her insights into insurance coverage, the role of specialty pharmacies, and patient advocacy efforts to improve access to novel MDD therapies.
Advertisement
Episodes in this series

Newsletter
Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
Southern California Psychiatry: Review of New Agents in Schizophrenia and Dementia
2
Programs for ST-905 and ST-905 for Schizophrenia and Depression Launched by Syremis Therapeutics
3
Cobenfy for Treatment of Schizophrenia Now Approved in China
4
Reflecting on Tales From the Clinic in 2025
5















